G. L. Amidon, 1995, Pharm. Res., 12, 413, 10.1023/A:1016212804288
E. Galia, 1998, Pharm. Res., 15, 698, 10.1023/A:1011910801212
E. Nicolaides, 2001, Pharm. Res., 18, 380, 10.1023/A:1011071401306
M. Vertzoni, 2005, Eur. J. Pharm. Biopharm., 60, 413, 10.1016/j.ejpb.2005.03.002
J. B. Dressman, 1998, Pharm. Res., 15, 11, 10.1023/A:1011984216775
N. Fotaki, 2005, Eur. J. Pharm. Sci., 24, 115, 10.1016/j.ejps.2004.10.003
N. Fotaki, M. Symillides, C. Reppas. Canine vs. in vitro data for predicting input profiles of L-sulpiride after oral administration. Eur. J. Pharm. Sci. 26:324–333 (2005).
Guidance for Industry, Bioavailability and Bioequivalence studies for orally administered drug products—General considerations, U.S. Department of Health and Human Services, FDA, CDER, October 2000.
EMEA, Committee for proprietary medicinal products, Note for guidance for the investigation of bioavailability and bioequivalence, CPMP/EWP/QWP/1404/98, 26 July 2001.
L. Ovesen, 1986, Gastroenterology, 90, 958, 10.1016/0016-5085(86)90873-5
J. R. Malagelada, 1976, Gastroenterology, 70, 203, 10.1016/S0016-5085(76)80010-8
V. Savarino, 1988, Dig. Dis. Sci., 33, 1077, 10.1007/BF01535781
J. B. Dressman, 1990, Pharm. Res., 7, 756, 10.1023/A:1015827908309
A. Lindahl, 1997, Pharm. Res., 14, 497, 10.1023/A:1012107801889
A. G. Press, 1998, Aliment. Pharmacol. Ther., 12, 673, 10.1046/j.1365-2036.1998.00358.x
L. J. Miller, 1978, Gut, 19, 699, 10.1136/gut.19.8.699
Guidance for Industry, Food-Effect Bioavailability and Fed Bioequivalence Studies, U.S. Department of Health and Human Services, FDA, CDER, December 2002.
W. P. Geus, 1999, Aliment. Pharmacol. Ther., 13, 937, 10.1046/j.1365-2036.1999.00543.x
H. A. Schmidt, 1970, Dtsch. Med. Wochenschr., 95, 2011, 10.1055/s-0028-1108771
D. P. Mertz, 1968, Klin. Wochenschr., 46, 820, 10.1007/BF01745650
The Ross Medical Nutritional System, Product Handbook, Ross Laboratories, Ross Products Division, Abbott Laboratories, Columbus, OH, USA, 1993.
S. Klein, 2004, J. Pharm. Pharmacol., 56, 605, 10.1211/0022357023367
National Institutes of Health, 1998, Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults
M. Vertzoni, Optimization of in vitro dissolution conditions for the prediction of oral absorption characteristics of lipophilic compounds. Doctoral Thesis, National and Kapodistrian University of Athens, Athens, Greece, 2004.
D. D. Van Slyke, 1922, J. Biol. Chem., 52, 525, 10.1016/S0021-9258(18)85845-8
A. T. Florence, 1988, Physicochemical Principles of Pharmacy, 10.1007/978-1-349-16558-2
C. J. Gara, 1986, Scand. J. Gastroenterol., 21, 650, 10.3109/00365528609011096
P. Gegenheimer, 1990, Methods Enzymol., 182, 174, 10.1016/0076-6879(90)82016-U
J. C. Miller, 1984, Statistics for Analytical Chemistry, Chap. 4, 90
M. L. Anson, 1938, J. Gen. Physiol., 22, 79, 10.1085/jgp.22.1.79
M. Vertzoni, 2004, J. Pharm. Pharmacol., 56, 453, 10.1211/0022357022935
S. J. Malawer, 1967, Gastroenterology, 53, 250, 10.1016/S0016-5085(19)34232-5
T. B. Buxton, 1979, Gastroenterology, 76, 820, 10.1016/S0016-5085(79)80184-5
D. S. Galanos, 1965, Biochim. Biophys. Acta, 98, 278, 10.1016/0005-2760(65)90121-9
A. Dupois, 1977, J. Clin. Invest., 59, 225
J. Sarosiek, 1994, Am. J. Med. Sci., 308, 23, 10.1097/00000441-199407000-00006
H. W. Davenport, 1981, Physiology of Digestive Tract, 5
R. Lambert, 1968, Digestion, 1, 65, 10.1159/000196835
C. V. Gisolfi, 1998, J. Appl. Physiol., 85, 1941, 10.1152/jappl.1998.85.5.1941
P. Finholt, 1968, J. Pharm. Sci., 57, 1322, 10.1002/jps.2600570809
M. Efentakis, 1998, Eur. J. Drug Metab. Pharmacokinet., 23, 97, 10.1007/BF03189322
M. Gidaldi, 1970, J. Pharm. Sci., 55, 579
J. Rhodes, 1969, Gastroenterology, 57, 241, 10.1016/S0016-5085(19)33895-8
M. Efentakis, 1981, Acta Pharm. Technol., 27, 33
L. J. Naylor, 1993, Pharm. Res., 10, 865, 10.1023/A:1018961227717
J. T. Fell, 1995, Int. J. Pharm., 125, 327, 10.1016/0378-5173(95)00153-A
B. L. Pedersen, 2000, Pharm. Res., 17, 891, 10.1023/A:1007576713216
J. S. Fordtran, 1973, J. Clin. Invest., 52, 645, 10.1172/JCI107226
W. Woodtli, 1995, Am. J. Physiol., 268, G146
J. Fallingborg, 1989, Aliment. Pharmacol. Ther., 3, 605, 10.1111/j.1365-2036.1989.tb00254.x
G. Pye, 1990, Gut, 31, 1355, 10.1136/gut.31.12.1355
D. P. McNamara, 2003, Pharm Res., 20, 1641, 10.1023/A:1026147620304
M. Repisthi, 2001, Am. J. Physiol.: Gasterointest. Liver Physiol., 281, G159
D. H. Alpers, 1987, Physiology of Gastrointestinal Tract, 2
S. J. Rune, 1972, Gastroenterology, 62, 533, 10.1016/S0016-5085(72)80035-0
J. B. Hunt, 1992, Gut, 33, 479, 10.1136/gut.33.4.479
J. B. Hunt, 1989, Aliment. Pharmacol. Ther., 3, 565, 10.1111/j.1365-2036.1989.tb00249.x
A. Pfeiffer, 1998, Aliment. Pharmacol. Ther., 12, 281, 10.1046/j.1365-2036.1998.00301.x
J. B. Leiper, 1986, J. Physiol. (Lond.), 373, 90
J. B. Hunt, 1992, Gut, 33, 1652, 10.1136/gut.33.12.1652
M. Armand, 1996, Am. J. Phys., 271, G172, 10.1152/ajpcell.1996.271.1.C172
O. Fausa, 1974, Scand. J. Gastroenterol., 9, 567, 10.1080/00365521.1974.12096876
M. Polonovski, 1952, Bull. Soc. Chim. Biol., 34, 703
A. M. Stephen, 1983, Gastroenterology, 85, 589, 10.1016/0016-5085(83)90012-4
J. H. Bond, 1972, J. Clin. Invest., 51, 1219, 10.1172/JCI106916
J. H. Bond, 1980, Gastroenterology, 78, 444, 10.1016/0016-5085(80)90854-9
